Faced with the prospect of needing major surgery, most people will be anxious and desperate for information, but often don’t ask the right questions of their doctors, says
Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the rang
Digital health company Akili has launched a non-prescription version of its attention-deficit hyperactivity disorder (ADHD) digital therapeutic EndeavorRx, that can be dow
Personalised and precision health is a firmly established concept in the development of new prescription medicines, but not so much in the consumer health category.
A new clinical study has found that a wearable device developed by PD Neurotechnology was 95% accurate in detecting and assessing motor symptoms of Parkinson’s disease, wh
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.